Stereotactic Ablative Radiation Therapy for Oligoprogressive Renal Cell Carcinoma

Advances in Radiation Oncology(2021)

引用 15|浏览1
暂无评分
摘要
SAbR has the potential to extend the the duration of current systemic therapy for selected patients with mRCC, preserving subsequent therapies for later administration possibly enabling longer treatment duration.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要